These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14559329)

  • 21. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART.
    Calza L; Manfredi R; Chiodo F
    AIDS; 2003 Apr; 17(6):851-9. PubMed ID: 12660532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART.
    Calza L; Manfredi R; Chiodo F
    Infection; 2002 Jan; 30(1):26-31. PubMed ID: 11876511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of fluvastatin and fenofibrate on the antioxidative barrier enzyme activity in patients with dyslipidemia].
    Kowalski J; Olejniczak J; Błaszczyk J; Błaszczyk-Suszyńska J; Kowalski M; Petecka E; Kedziora J
    Pol Merkur Lekarski; 2003 Apr; 14(82):285-8. PubMed ID: 12868185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.
    Aberg JA; Zackin RA; Brobst SW; Evans SR; Alston BL; Henry WK; Glesby MJ; Torriani FJ; Yang Y; Owens SI; Fichtenbaum CJ;
    AIDS Res Hum Retroviruses; 2005 Sep; 21(9):757-67. PubMed ID: 16218799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pravastatin and fenofibrate in combination (Pravafenix(®)) for the treatment of high-risk patients with mixed hyperlipidemia.
    Farnier M
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):565-75. PubMed ID: 22651832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 27. Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.
    Adkins JC; Faulds D
    Drugs; 1997 Oct; 54(4):615-33. PubMed ID: 9339964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of statin and fibrate on lowering small dense LDL- cholesterol in hyperlipidemic patients with type 2 diabetes.
    Tokuno A; Hirano T; Hayashi T; Mori Y; Yamamoto T; Nagashima M; Shiraishi Y; Ito Y; Adachi M
    J Atheroscler Thromb; 2007 Jun; 14(3):128-32. PubMed ID: 17587764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia.
    Chuck SK; Penzak SR
    Expert Opin Drug Saf; 2002 May; 1(1):5-17. PubMed ID: 12904155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of fluvastatin and fenofibrate on reactive oxygen species generation and lipid peroxidation in patients with dyslipidemia].
    Kowalski J; Błaszczyk J; Olejniczak J; Kowalski M; Błaszczyk-Suszyńska J; Petecka E; Kedziora J; Gburek J
    Pol Merkur Lekarski; 2003 Apr; 14(82):279-84. PubMed ID: 12868184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correction of atherogenic exogenously-induced postprandial hyperlipidemia with pravastatin].
    Bubnova MG; Aronov DM; Perova NV; Olfer'ev AM; Golubev MA; Mel'kina OE; Zhasminova VG
    Kardiologiia; 2002; 42(1):27-32. PubMed ID: 12494220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperlipidemia associated with protease inhibitor therapy.
    Echevarria KL; Hardin TC; Smith JA
    Ann Pharmacother; 1999; 33(7-8):859-63. PubMed ID: 10466916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic complications of HIV and AIDs.
    Briggs JM; Drabek CA
    Orthop Nurs; 2001; 20(4):41-50. PubMed ID: 12025672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of micronized fenofibrate and pravastatin in patients with primary hyperlipidemia.
    Ducobu J; VanHaelst L; Salomon H
    J Cardiovasc Pharmacol; 2003 Jan; 41(1):60-7. PubMed ID: 12500022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked hyperlipidaemia on ritonavir therapy.
    Sullivan AK; Nelson MR
    AIDS; 1997 Jun; 11(7):938-9. PubMed ID: 9189227
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent developments in HIV research.
    Boyle BA
    AIDS Read; 2002 Sep; 12(9):390-4, 407. PubMed ID: 12402802
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia.
    Mostaza JM; Schulz I; Vega GL; Grundy SM
    Am J Cardiol; 1997 May; 79(9):1298-301. PubMed ID: 9164913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.
    Lemieux I; Laperrière L; Dzavik V; Tremblay G; Bourgeois J; Després JP
    Atherosclerosis; 2002 Jun; 162(2):363-71. PubMed ID: 11996956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 40. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
    Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P
    Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.